{
    "clinical_study": {
        "@rank": "161333", 
        "arm_group": [
            {
                "arm_group_label": "CML CP", 
                "description": "Diagnosed as CML with chronic phase"
            }, 
            {
                "arm_group_label": "CML AP", 
                "description": "Diagnosed as CML with accelerated phase"
            }, 
            {
                "arm_group_label": "CML BC", 
                "description": "Diagnosed as CML with blast crisis"
            }, 
            {
                "arm_group_label": "CML other", 
                "description": "Diagnosed as CML, which is not included in any of other category"
            }
        ], 
        "biospec_descr": {
            "textblock": "Bone marrow aspirate or peripheral blood (for its mononuclear cells) will be collected,\n      processed, and cryopreserved for future analysis of DNA or cell culture. Acquisition of\n      biospecimens will be proceeded if patient agree with the informed consent for donation of\n      biospecimen to 'Asan Medical Center Biomaterial Resource Banking Center'. This registry data\n      will be used as a basic demographic and clinical information for the biospecimens."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The investigators would like to propose a prospective longitudinal observational cohort\n      study for patients who will be diagnosed and/or treated for chronic myeloid leukemia at Asan\n      Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other\n      retrospective analysis."
        }, 
        "brief_title": "Chronic Myelod Leukemia Registry at Asan Medical Center", 
        "completion_date": {
            "#text": "December 2047", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Leukemia, Chronic Myeloid", 
            "Myeloid Leukemia, Chronic, Accelerated Phase", 
            "Myeloid Leukemia, Chronic, Chronic Phase"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Myeloid", 
                "Leukemia, Myeloid, Accelerated Phase", 
                "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", 
                "Leukemia, Myeloid, Chronic-Phase", 
                "Chronic Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "1. Acquisition of informed concent form\n\n        2. Data acquisition from medical record including\n\n             -  demographic / disease-associated factors\n\n             -  details of treatment, and its results\n\n             -  complications during treatment\n\n             -  genetic data\n\n             -  survival outcome (upto 30 years)\n\n        3. Accumulation of data for 30 years\n\n        4. Use of data for other retrospective analysis (including Asan Medical center Cell\n           Banking basic data)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients who are diagnosed and/or treated as chronic myeloid leukemia at Asan\n             Medical Center\n\n          -  15 years of age and over\n\n          -  All patients who give written consent according to guidelines at Asan Medical Center\n             committee on human research\n\n        Exclusion Criteria:\n\n          -  Patients who refuse to give consent to registering"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "15 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who are diagnosed and/or treated with chronic myeloid leukemia at Asan Medical\n        Center, Seoul, Korea"
            }
        }, 
        "enrollment": {
            "#text": "1050", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761695", 
            "org_study_id": "AMC-HEMREG-CML"
        }, 
        "intervention": {
            "arm_group_label": [
                "CML CP", 
                "CML AP", 
                "CML BC", 
                "CML other"
            ], 
            "description": "All patients who will be enrolled in this prospective registry are confined to those who are diagnosed as chronic myeloid leukemia at Asan Medical Center, Seoul, Korea, from Jan 2013 till Dec 2047", 
            "intervention_name": "Diagnosed as CML", 
            "intervention_type": "Other", 
            "other_name": "Diagnosed as chronic myeloid leukemia"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 1, 2014", 
        "location": {
            "contact": {
                "email": "claudiana@naver.com", 
                "last_name": "Seo Hyun Na, RN", 
                "phone": "82-2-3010-8261"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "Asan Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Kyoo-Hyung Lee, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Dae-Young Kim, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Je-Hwan Lee, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jung-Hee Lee, MD, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "4", 
        "official_title": "Prospective Observational Cohort Registry for Patients With Chronic Myeloid Leukemia at Asan Medical Center", 
        "overall_contact": {
            "email": "claudiana@naver.com", 
            "last_name": "Seo Hyun Na, RN", 
            "phone": "82-2-3010-8261"
        }, 
        "overall_official": {
            "affiliation": "Assistant Professor", 
            "last_name": "Dae-Young Kim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2047", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Overall survival", 
            "safety_issue": "No", 
            "time_frame": "30 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761695"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Dae-Young Kim", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Definition of events will be as 'failure', 'progress to AP/BC', 'intolerant and medication change', and 'death from any cause'.", 
                "measure": "Event-free survival", 
                "safety_issue": "No", 
                "time_frame": "30 years"
            }, 
            {
                "description": "Failure will be defined as BCR-ABL elevation at 2 serial times, progression to AP/BC, loss of hematologic / cytogenetic response, any appearance of ABL kinase mutation, and clonal evolution.", 
                "measure": "Failure-free survival", 
                "safety_issue": "No", 
                "time_frame": "30 years"
            }
        ], 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "30 Years", 
        "verification_date": "January 2014"
    }
}